SARTORI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 7.033
AS - Asia 3.906
EU - Europa 2.978
SA - Sud America 630
AF - Africa 98
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 11
Totale 14.704
Nazione #
US - Stati Uniti d'America 6.896
SG - Singapore 1.371
CN - Cina 1.282
UA - Ucraina 607
BR - Brasile 551
HK - Hong Kong 523
DE - Germania 496
IT - Italia 468
PL - Polonia 343
FI - Finlandia 259
GB - Regno Unito 205
VN - Vietnam 179
RU - Federazione Russa 163
TR - Turchia 163
IE - Irlanda 136
CA - Canada 86
IN - India 84
FR - Francia 74
ID - Indonesia 57
BD - Bangladesh 53
SE - Svezia 52
ZA - Sudafrica 42
AU - Australia 40
MX - Messico 35
JP - Giappone 34
IQ - Iraq 33
AR - Argentina 31
ES - Italia 31
NL - Olanda 25
EE - Estonia 23
SA - Arabia Saudita 22
AT - Austria 15
EC - Ecuador 15
CZ - Repubblica Ceca 14
MY - Malesia 14
BE - Belgio 13
MA - Marocco 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 10
EU - Europa 10
BG - Bulgaria 8
IL - Israele 8
JO - Giordania 8
PY - Paraguay 8
EG - Egitto 7
GR - Grecia 7
LT - Lituania 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
UZ - Uzbekistan 7
KE - Kenya 6
LK - Sri Lanka 6
MU - Mauritius 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
VE - Venezuela 6
NP - Nepal 5
PE - Perù 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
KG - Kirghizistan 4
KR - Corea 4
NG - Nigeria 4
AZ - Azerbaigian 3
BY - Bielorussia 3
ET - Etiopia 3
OM - Oman 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
CM - Camerun 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PH - Filippine 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AO - Angola 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
Totale 14.693
Città #
Fairfield 745
Singapore 696
Woodbridge 685
Ashburn 610
Hong Kong 515
Jacksonville 438
Houston 370
Chandler 364
Warsaw 338
Seattle 312
Cambridge 284
Beijing 278
Wilmington 251
Princeton 240
Ann Arbor 238
New York 203
Los Angeles 186
Helsinki 149
Nanjing 145
Dublin 136
Istanbul 136
Munich 113
Dearborn 109
Brescia 106
Shanghai 79
Moscow 78
Des Moines 74
Nanchang 63
São Paulo 63
Redondo Beach 62
The Dalles 62
Ho Chi Minh City 61
Dallas 58
Shenyang 58
Chicago 56
San Francisco 55
Changsha 54
Buffalo 53
Jinan 46
San Diego 45
Tianjin 42
Hanoi 41
Milan 41
Jakarta 37
Jiaxing 36
London 35
Hebei 34
Guangzhou 33
Toronto 31
Turku 31
Chennai 29
Denver 29
Kunming 28
Montreal 27
Brooklyn 26
Tokyo 26
Johannesburg 25
Santa Clara 25
Stockholm 23
Tallinn 23
Dong Ket 22
Rome 22
Taizhou 22
Nuremberg 21
Verona 21
Boston 20
Hangzhou 18
Poplar 18
Zhengzhou 18
Atlanta 16
Manchester 16
Frankfurt am Main 15
Lanzhou 15
Orem 15
Phoenix 15
Romola 15
Belo Horizonte 14
Düsseldorf 14
Rio de Janeiro 14
Brussels 13
Campinas 13
Charlotte 13
Dhaka 13
Falkenstein 13
Lappeenranta 12
Melbourne 12
Lancaster 11
Baghdad 10
Curitiba 10
Ankara 9
Mexico City 9
Mumbai 9
Ningbo 9
Amman 8
Boardman 8
Delhi 8
Hefei 8
Monmouth Junction 8
Norwalk 8
Porto Alegre 8
Totale 9.779
Nome #
Preeclampsia and late fetal growth restriction 334
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 326
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 212
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 196
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 188
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 183
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 180
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 166
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 166
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 165
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 162
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 161
Analysis of the evolution in the management of endometrial cancer in Italy: a CTF study. 150
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). 148
Prognostic factors in early-stage ovarian cancer. 147
Early stage cervical cancer: adjuvant treatment in negative lymph node cases. 140
Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. 140
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 140
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study). 140
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 138
The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation 135
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 134
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 134
An Analysis of approaches to th treatment of endometrial cancer in western Europe: a CTF study 133
null 132
An analysis of approaches to the management of endometrial cancer in North America: a CTF study 131
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 131
Fetal anemia: Diagnosis and management 131
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 131
Identification of a new mutation in the SRY gene in a 46,XY woman with Swyer syndrome. 130
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 129
Twin reversed arterial perfusion sequence: current treatment options 127
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 125
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 124
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 122
Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors 122
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 121
New development of the FIGO staging system. 121
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. 121
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 121
Learning climate and quality of postgraduate training in gynecology and obstetrics should be assessed in italian training courses 121
Endometrial stromal sarcoma: analysis of treatment failures and survival 120
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 120
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 117
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. 114
Bowel obstruction and survival in patients with advanced ovarian cancer: analysis of prognostic variables. 114
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. 114
Palliative care in advanced ovarian cancer patients with bowel obstruction 111
The role of HE4 in ovarian cancer follow-up: a review. 110
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 108
Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19 108
Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study 107
Management of borderline ovarian tumors: results of an italian multicenter study 105
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study 105
Analysis of failure after negative second look in patients with advanced ovarian cancer: an italian multicenter study 104
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. 103
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 103
Cancer in pregnancy: maternal and fetal implications on decision-making. 101
Are surveillance procedures of clinical benefit forpatients treated for ovarian cancer?: A retrospective Italian multicentric study. 100
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 100
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 100
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 99
Follow-up strategies in gynecological oncology: searching appropriateness. 98
Adiponectin modulation by hyperandrogenism and insulin-resistance in polycystic ovary syndrome and normal women 95
An analysis of different approaches to ovarian cysts in Italy. 92
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 92
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 90
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 90
Prenatal ultrasound diagnosis of cavitation of the ganglionic eminence 88
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
Cancer in Pregnancy: safety of chemotherapy on fetal outcome 87
Surveillance procedures for patients with cervical carcinoma: a review of the literature. 87
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 86
A case of combined aortic bioprosthetic valve degeneration and patient-prosthesis mismatch during pregnancy: decision-making and implications after pregnancy. 85
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis. 84
Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks 84
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 84
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases 83
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 83
Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study. 81
Possible Coronavirus Disease 2019 Pandemic and Pregnancy: Vertical Transmission Is Not Excluded 81
The prognostic value of antenatal ultrasound in cases complicated by fetal ovarian cysts 81
A strange case of pleuritic pain in the third trimester of pregnancy 80
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patiants with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collqaborative Study 80
Surveillance procedures for patients treated for endometrial cancer: a review of the literature. 80
Folic acid supplementation in pregnancy: A matter of doses? 80
Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature 80
Approcio anatomo clinico alla patologia dell'uteroin Diagnostica per immagini dell'apparato urogenitale 79
Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection 79
Surveillance procedures for patients for cervical carcinoma: a review of the literature. 78
Clinical review of 55 cases of malignant ovarian germ cell tumors. 78
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta 78
Pretreatment platele and hemoglobin levels are neither predictive non prognostic variables for patients with locally advanced ccervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study 77
Clear cell endometrial cancer: a CTF multicentre Italian study 77
Pre-chemoterapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who recwivwe a first-line taxane/platinum-based regimen: results of a multicenter retrospective italian study. 77
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 76
Relationship between time interval from primary surgery to the start of taxane- plus platinum – based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: result of a multicenter retrospective italian study 76
Ploidy and S-phase fraction as possible prognostic factors in endometrial carcinoma: a review of 52 cases. 75
Totale 11.890
Categoria #
all - tutte 81.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.137 0 0 0 0 0 194 79 189 194 238 165 78
2021/20221.062 71 195 20 48 19 30 93 83 62 99 96 246
2022/20231.038 152 37 46 49 88 260 12 116 153 5 62 58
2023/20241.156 84 27 92 103 45 178 73 55 296 29 20 154
2024/20252.921 19 93 79 393 285 288 270 101 323 192 576 302
2025/20263.151 610 676 338 783 672 72 0 0 0 0 0 0
Totale 14.909